|
FAM114A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.684000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.486000E-01 |
| Normal-vs-Stage2 |
1.765580E-01 |
| Normal-vs-Stage3 |
7.630200E-02 |
| Normal-vs-Stage4 |
3.581900E-02 |
| Stage1-vs-Stage2 |
3.498800E-01 |
| Stage1-vs-Stage3 |
4.996300E-03 |
| Stage1-vs-Stage4 |
2.235200E-03 |
| Stage2-vs-Stage3 |
2.106100E-02 |
| Stage2-vs-Stage4 |
1.127860E-02 |
| Stage3-vs-Stage4 |
6.438600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.398000E-01 |
| Normal-vs-AfricanAmerican |
2.722100E-03 |
| Normal-vs-Asian |
7.048400E-01 |
| Caucasian-vs-AfricanAmerican |
7.794000E-04 |
| Caucasian-vs-Asian |
7.756400E-01 |
| AfricanAmerican-vs-Asian |
3.169600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.218600E-01 |
| Normal-vs-Female |
7.458400E-01 |
| Male-vs-Female |
8.985400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.832800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.679000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.744200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.611600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.839800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.446200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.950400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.972400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.339400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.463400E-01 |
| Normal-vs-Grade 2 |
2.566200E-01 |
| Normal-vs-Grade 3 |
6.997200E-01 |
| Normal-vs-Grade 4 |
3.376500E-03 |
| Grade 1-vs-Grade 2 |
7.034200E-01 |
| Grade 1-vs-Grade 3 |
3.409000E-01 |
| Grade 1-vs-Grade 4 |
3.177600E-02 |
| Grade 2-vs-Grade 3 |
1.235600E-01 |
| Grade 2-vs-Grade 4 |
1.818380E-04 |
| Grade 3-vs-Grade 4 |
6.339400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.224800E-04 |
| Normal-vs-ccB subtype |
1.031530E-02 |
| ccA subtype-vs-ccB subtype |
4.91609974950791E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.126000E-01 |
| Normal-vs-N1 |
6.565800E-02 |
| N0-vs-N1 |
6.154200E-02 |
|
|
